Pediatr. praxi. 2024;25(4):206-212 | DOI: 10.36290/ped.2024.041

Empirical oral antibiotic therapy for the most common acute community-acquired bacterial infections in children

MUDr. Marek Štefan, MBA1, PharmDr. Jindřich Havránek2, PharmDr. Markéta Petrželová2, Mgr. Jitka Gambacorta2, Mgr. Markéta Kulakowská2, PharmDr. Šárka Nováková2, PharmDr. Dagmar Dolinská2, Mgr. Antónia Modráková2, PharmDr. Alena Valko2, MUDr. Otakar Nyč, Ph.D.3, MUDr. Jana Tejnická, MBA4, doc. MUDr. Jakub Zieg, Ph.D.4, MUDr. Petra Dytrych, Ph.D.5, MUDr. Milan Trojánek, Ph.D.1, MUDr. Jitka Müllerová-Dissou, MBA6
1 Klinika infekčních nemocí a cestovní medicíny 2. LF UK a FN Motol, Praha
2 Nemocniční lékárna FN Motol, Praha
3 Ústav lékařské mikrobiologie 2. LF UK a FN Motol, Praha
4 Pediatrická klinika 2. LF UK a FN Motol, Praha
5 Klinika ušní, nosní a krční 2. LF UK a FN Motol, Praha
6 Oddělení urgentního příjmu a LSPP dětí FN Motol, Praha

This article addresses the issue of empirical oral antibiotic therapy for the most common acute community-acquired bacterial infections in children, specifically tonsillitis, otitis media, sinusitis, pneumonia, cystitis, pyelonephritis, erysipelas, cellulitis, impetigo, and erythema migrans. In addition to first-choice antibiotics, alternatives are provided in cases of antibiotic shortages or allergies. The recommendations also include magistral (compounded, pharmacist-prepared) formulas for selected antibiotics. The article further focuses on the AWaRe classification of antibiotics, which divides available antibiotics into three groups according to the risk of inducing bacterial resistance.

Keywords: antibiotics, bacterial infections, selection pressure, allergy, AWaRe classification.

Accepted: August 27, 2024; Published: September 5, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štefan M, Havránek J, Petrželová M, Gambacorta J, Kulakowská M, Nováková Š, et al.. Empirical oral antibiotic therapy for the most common acute community-acquired bacterial infections in children. Pediatr. praxi. 2024;25(4):206-212. doi: 10.36290/ped.2024.041.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infections: do antibiotic prescriptions improve outcomes? J Okla State Med Assoc. 1996;89(8):267-274.
    2. Nyquist AC, Gonzales R, Steiner JT, et al. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279(11):875-877. Go to original source... Go to PubMed...
    3. Alves Galvao MG, Rocha Crispino Santos MA, Alves da Cunha AJ. Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age. Cochrane Database Syst Rev. 2016;2:CD007880. Go to original source... Go to PubMed...
    4. Albrich WC, Monnet DL, Harbath S. Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis. 2004;10(3):514-517. Go to original source... Go to PubMed...
    5. Státní zdravotní ústav. Projekt "Prevence antibiotické rezistence". Nová klinická doporučení pro antibiotickou terapii v ambulantní praxi [online]. Nedatováno [cit. 2024-05-09]. Dostupné na: https://www.antibiotickarezistence.cz/taxonomy/doporuceni/.
    6. WHO. AWaRe: WHO Antibiotic categorization [online]. Nedatováno [cit. 2024-05-09]. Dostupné na: https://aware.essentialmeds.org/groups.
    7. WHO Model List of Essential Medicines for Children - 9th list, 2023 [online]. 2023-07-26 [cit. 2024-05-09]. Dostupné na: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.03
    8. Ministerstvo zdravotnictví ČR. Věstník, č 04/2024 [online]. 2024-03-24 [cit. 2024-05-09]. Dostupné na: https://mzd.gov.cz/vestnik/vestnik-4-2024/.
    9. Evropská komise. Návrhu DOPORUČENÍ RADY o posílení opatření EU pro boj proti antimikrobiální rezistenci v rámci přístupu "jedno zdraví" [online]. 2023-03-26 [cit. 2024-05-09]. Dostupné na: https://eur-lex.europa.eu/resource.html?uri=cellar:9b17c109-e438-11ed-a05c-01aa75ed71a1.0016.02/DOC_2&format=PDF
    10. Státní zdravotní ústav. Močová studie ATB rezistence [online]. 2021-04-24 [cit. 2024-05-09]. Dostupné na: https://archiv.szu.cz/mocova-studie-atb-rezistence.
    11. Státní zdravotní ústav. Databáze výsledků studie "RESPIRAČNÍ PATOGENY" [online]. Nedatováno [cit. 2024-05-09]. Dostupné na: https://apps.szu.cz/rp/respiracni_patogeny.php.
    12. Wijnakker R, van Maaren MS, Bode LGM, et al. The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy. Clin Microbiol Infect. 2023;29(7):863-875. Go to original source... Go to PubMed...
    13. Centor Score (Modified/McIsaac) for Strep Pharyngitis. MDCalc [online]. Nedatováno [cit. 2024-05-09]. Dostupné na: https://www.mdcalc.com/calc/104/centor-score-modified-mcisaac-strep-pharyngitis#evidence
    14. NICE Guideline. Otitis media (acute): antimicrobial prescribing [online]. 2022-03-11 [cit. 2024-05-09]. Dostupné na: https://www.nice.org.uk/guidance/ng91/chapter/Recommendations#choice-of-treatment
    15. Sakulchit T, Goldman RD. Antibiotic therapy for children with acute otitis media. Can Fam Physician. 2017; 63(9):685-687.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.